These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 25038272)
1. Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme. Ruggieri S; Tamma R; Marzullo A; Annese T; Marinaccio C; Errede M; Susca FC; Senetta R; Cassoni P; Vacca A; Albano F; Saracino C; Notarangelo A; Specchia G; Ribatti D; Nico B Cancer Lett; 2014 Oct; 353(1):41-51. PubMed ID: 25038272 [TBL] [Abstract][Full Text] [Related]
2. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas]. Yu S; Pu P; Jiang D; An T; Guan X; Yang L Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884 [TBL] [Abstract][Full Text] [Related]
3. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. Ray SK; Patel SJ; Welsh CT; Wilford GG; Hogan EL; Banik NL J Neurosci Res; 2002 Jul; 69(2):197-206. PubMed ID: 12111801 [TBL] [Abstract][Full Text] [Related]
4. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818 [TBL] [Abstract][Full Text] [Related]
7. Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo. Deininger MH; Grote E; Wickboldt J; Meyermann R J Neurooncol; 2000 Jun; 48(2):121-9. PubMed ID: 11083075 [TBL] [Abstract][Full Text] [Related]
8. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas? Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489 [TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal. Martin S; Toquet C; Oliver L; Cartron PF; Perrin P; Meflah K; Cuillère P; Vallette FM J Neurooncol; 2001 Apr; 52(2):129-39. PubMed ID: 11508812 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714 [TBL] [Abstract][Full Text] [Related]
12. Role of Wnt5a in the proliferation of human glioblastoma cells. Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179 [TBL] [Abstract][Full Text] [Related]
13. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609 [TBL] [Abstract][Full Text] [Related]
14. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells? Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378 [TBL] [Abstract][Full Text] [Related]
15. The role of immunohistochemistry in predicting behavior of astrocytic tumors. Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628 [TBL] [Abstract][Full Text] [Related]
16. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy. Tang C; Guo J; Chen H; Yao CJ; Zhuang DX; Wang Y; Tang WJ; Ren G; Yao Y; Wu JS; Mao Y; Zhou LF Int J Clin Exp Pathol; 2015; 8(5):5327-35. PubMed ID: 26191234 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival. Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789 [TBL] [Abstract][Full Text] [Related]
18. Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC Mol Med Rep; 2013 Jan; 7(1):139-43. PubMed ID: 23076250 [TBL] [Abstract][Full Text] [Related]
19. Characterization of genetic lesions in apoptosis-regulating and proliferation control genes in diffuse large B-cell non-Hodgkin's lymphoma. Pervez S; Nasir MI; Moatter T; Ahsan A; Haq A; Siddiqui T J Cancer Res Ther; 2009; 5(4):254-62. PubMed ID: 20160358 [TBL] [Abstract][Full Text] [Related]
20. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma. Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]